Difference between revisions of "Drug index"
Jump to navigation
Jump to search
m |
|||
| Line 9: | Line 9: | ||
*[[Altretamine (Hexalen)]] | *[[Altretamine (Hexalen)]] | ||
*[[Aminoglutethimide (Cytadren)]] | *[[Aminoglutethimide (Cytadren)]] | ||
| + | *[[Amsacrine (Amsidine)]] | ||
*[[Anagrelide (Agrylin)]] | *[[Anagrelide (Agrylin)]] | ||
*[[Anastrozole (Arimidex)]] | *[[Anastrozole (Arimidex)]] | ||
| Line 37: | Line 38: | ||
*[[Cyclophosphamide (Cytoxan)]] | *[[Cyclophosphamide (Cytoxan)]] | ||
*[[Cytarabine (Cytosar)]] | *[[Cytarabine (Cytosar)]] | ||
| − | *[[Cytarabine | + | *[[Cytarabine liposomal (DepoCyt)]] |
==D== | ==D== | ||
| Line 44: | Line 45: | ||
*[[Dasatinib (Sprycel)]] | *[[Dasatinib (Sprycel)]] | ||
*[[Daunorubicin (Cerubidine)]] | *[[Daunorubicin (Cerubidine)]] | ||
| − | *[[Daunorubicin | + | *[[Daunorubicin liposomal (Daunoxome)]] |
*[[Decitabine (Dacogen)]] | *[[Decitabine (Dacogen)]] | ||
*[[Degarelix (Firmagon)]] | *[[Degarelix (Firmagon)]] | ||
| Line 50: | Line 51: | ||
*[[Docetaxel (Taxotere)]] | *[[Docetaxel (Taxotere)]] | ||
*[[Doxorubicin (Adriamycin)]] | *[[Doxorubicin (Adriamycin)]] | ||
| − | *[[Doxorubicin | + | *[[Doxorubicin liposomal (Doxil)]] |
*[[Dutasteride (Avodart)]] | *[[Dutasteride (Avodart)]] | ||
| Line 65: | Line 66: | ||
==F== | ==F== | ||
*[[Finasteride (Proscar) | *[[Finasteride (Proscar) | ||
| + | *[[Fluorouracil (5-FU)]] | ||
*[[Floxuridine (FDUR)]] | *[[Floxuridine (FDUR)]] | ||
*[[Fludarabine (Fludara)]] | *[[Fludarabine (Fludara)]] | ||
| Line 123: | Line 125: | ||
*[[Pemetrexed (Alimta)]] | *[[Pemetrexed (Alimta)]] | ||
*[[Pentostatin (Nipent)]] | *[[Pentostatin (Nipent)]] | ||
| + | *[[Plicamycin (Mithracin)]] | ||
*[[Porfimer (Photofrin)]] | *[[Porfimer (Photofrin)]] | ||
*[[Pralatrexate (Folotyn)]] | *[[Pralatrexate (Folotyn)]] | ||
| Line 150: | Line 153: | ||
*[[Toremifene (Fareston)]] | *[[Toremifene (Fareston)]] | ||
*[[Tositumomab & I-131 (Bexxar)]] | *[[Tositumomab & I-131 (Bexxar)]] | ||
| + | *[[Trabectedin (Yondelis)]] | ||
*[[Trastuzumab (Herceptin)]] | *[[Trastuzumab (Herceptin)]] | ||
*[[Tretinoin (Vesanoid)]] | *[[Tretinoin (Vesanoid)]] | ||
| Line 157: | Line 161: | ||
*[[Vinblastine (Velban)]] | *[[Vinblastine (Velban)]] | ||
*[[Vincristine (Oncovorin)]] | *[[Vincristine (Oncovorin)]] | ||
| + | *[[Vindesine (Eldisine)]] | ||
*[[Vinorelbine (Navelbine)]] | *[[Vinorelbine (Navelbine)]] | ||
*[[Vorinostat (Zolinza)]] | *[[Vorinostat (Zolinza)]] | ||
Revision as of 03:47, 17 November 2011
- List of chemotherapy regimens
- Vesicant & irritant chemotherapy
- Antiemetic support
- Third party patient information sheets (password protected)
- (List also includes non-chemotherapy medications used in hematology/oncology, such as aromatase inhibitors.)
A
- Aldesleukin (Proleukin)
- Alemtuzumab (Campath)
- Altretamine (Hexalen)
- Aminoglutethimide (Cytadren)
- Amsacrine (Amsidine)
- Anagrelide (Agrylin)
- Anastrozole (Arimidex)
- Arsenic trioxide (Trisenox)
- Asparaginase (Elspar)
- Azacitadine (Vidaza)
B
- Bacillus Calmette-Guerin (BCG)
- Bendamustine (Treanda)
- Bevacizumab (Avastin)
- Bexarotene (Targretin)
- Bicalutamide (Casodex)
- Bleomycin (Blenoxane)
- Bortezomib (Velcade)
- Busulfan (Busulfex)
C
- Cabazitaxel (Jevtana)
- Capecitabine (Xeloda)
- Carboplatin (Paraplatin)
- Carmustine (Bicnu)
- Cetuximab (Erbitux)
- Chlorambucil (Leukeran)
- Cisplatin (Platinol)
- Cladribine (Leustatin)
- Clofarabine (Clolar)
- Cyclophosphamide (Cytoxan)
- Cytarabine (Cytosar)
- Cytarabine liposomal (DepoCyt)
D
- Dacarbazine (DTIC)
- Dactinomycin (Cosmegen)
- Dasatinib (Sprycel)
- Daunorubicin (Cerubidine)
- Daunorubicin liposomal (Daunoxome)
- Decitabine (Dacogen)
- Degarelix (Firmagon)
- Denileukin Difitox (Ontak)
- Docetaxel (Taxotere)
- Doxorubicin (Adriamycin)
- Doxorubicin liposomal (Doxil)
- Dutasteride (Avodart)
E
- Epirubicin (Ellence)
- Eribulin (Halaven)
- Erlotinib (Tarceva)
- Estramustine (Emcyt)
- Etoposide (Vepesid)
- Everolimus (Afinitor)
- Estramustine (Emcyt)
- Exemestane (Aromasin)
F
- [[Finasteride (Proscar)
- Fluorouracil (5-FU)
- Floxuridine (FDUR)
- Fludarabine (Fludara)
- Flutamide (Eulexin)
- Fulvestrant (Faslodex)
G
H
I
- Ibritumomab (Zevalin)
- Idarubicin (Idamycin)
- Ifosfamide (Ifex)
- Imatinib (Gleevec)
- Ipilimumab (Yervoy)
- Interferon alfa-2a (Roferon-A)
- Interferon alfa-2b (Intron-A)
- Irinotecan (Camptosar)
- Ixabepilone (Ixempra)
L
M
- Mechlorethamine (Mustargen)
- Melphalan (Alkeran)
- Mercaptopurine (Purinethol)
- Methotrexate (MTX)
- Mitomycin (Mutamycin)
- Mitotane (Lysodren)
- Mitoxantrone (Novantrone)
N
O
P
- Paclitaxel (Taxol)
- Paclitaxel, nanoparticle albumin-bound (Abraxane)
- Panitumumab (Vectibix)
- Peg-asparginase (Oncospar)
- Pemetrexed (Alimta)
- Pentostatin (Nipent)
- Plicamycin (Mithracin)
- Porfimer (Photofrin)
- Pralatrexate (Folotyn)
- Procarbazine (Matulane)
R
S
T
- Tamoxifen (Nolvadex)
- Temozolmide (Temodar)
- Temsirolimus (Torisel)
- Teniposide (Vumon)
- Thalidomide (Thalomid)
- Thioguanine (Tabloid)
- Thiotepa (Thioplex)
- Topotecan (Hycamtin)
- Toremifene (Fareston)
- Tositumomab & I-131 (Bexxar)
- Trabectedin (Yondelis)
- Trastuzumab (Herceptin)
- Tretinoin (Vesanoid)
- Triptorelin (Trelstar LA)
V
- Vinblastine (Velban)
- Vincristine (Oncovorin)
- Vindesine (Eldisine)
- Vinorelbine (Navelbine)
- Vorinostat (Zolinza)
Z
Reference
Chemotherapy Order of Administration (ONS recommendations-PDF)